Radiation protection

Plus Therapeutics Announces DSMB Approval to Proceed into Eighth Cohort in ReSPECT™ Glioblastoma Trial

Retrieved on: 
Wednesday, June 16, 2021
Radiation, Ionizing radiation, Radioactivity, Radiation protection, Physical sciences, Radiobiology, Carcinogens, Mutagens, Gray

Twenty-one patients with recurrent GBM have been treated in the ReSPECT trial across seven cohorts to date.

Key Points: 
  • Twenty-one patients with recurrent GBM have been treated in the ReSPECT trial across seven cohorts to date.
  • In these patients, RNL has had no dose-limiting toxicities observed with absorbed radiation doses of up to 740 Gray per tumor.
  • The eighth cohort of the ReSPECT trial will implement a 40% increase in total radioactivity.
  • Plus Therapeutics is a clinical-stage pharmaceutical company whose radiotherapeutic portfolio is concentrated on nanoliposome-encapsulated radionuclides for several cancer targets.

CAES and SkyWater to Expand US Strategic Radiation Hardened Semiconductor Platform

Retrieved on: 
Monday, June 14, 2021
Technology, Mobile, Wireless, Nanotechnology, Automotive Manufacturing, Aerospace, Manufacturing, Defense, Other Defense, Contracts, Networks, Semiconductor, Security, Consumer electronics, Satellite, Radiation, Ionizing radiation, Physical sciences, Carcinogens, Mutagens, Radiation protection, Radioactivity, Radiobiology, Supply chain, Microelectronics, Radiation hardening, CAES, SkyWater Technology, CAES, SKYWATER TECHNOLOGY

The evolution of this strategic RadHard microelectronic design and manufacturing ecosystem will strengthen SkyWaters DOD-accredited Trusted, on-shore semiconductor supply chain.

Key Points: 
  • The evolution of this strategic RadHard microelectronic design and manufacturing ecosystem will strengthen SkyWaters DOD-accredited Trusted, on-shore semiconductor supply chain.
  • By partnering with CAES, we expect to accelerate our on-shore, Trusted ecosystem for strategic defense missions that require extremely specialized, radiation-immune microelectronic process technologies.
  • CAES is excited to partner with SkyWater and provide our expertise in trusted radiation hardened design and qualification to help strengthen the strategic, Trusted supply chain with products designed and manufactured here in America, said Mike Kahn, president and CEO of CAES.
  • We look forward to playing our part in close collaboration with SkyWater to meet the most demanding national security missions.

Insights on the Medical X-Ray Detectors Global Market to 2029 - A New Generation of X-ray Detectors are Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, June 14, 2021
Radiology, Health, Medical devices, Radiation, Ionizing radiation, Radiography, Medical imaging, Radiation protection, Radioactivity, Radiobiology, X-ray, Digital radiography, Semiconductor detector

This innovation forced many key players to develop extremely sensitive X-ray detectors that will reduce the radiation dose.

Key Points: 
  • This innovation forced many key players to develop extremely sensitive X-ray detectors that will reduce the radiation dose.
  • The X-ray photon energy is vital part of X-ray detectors as X-ray absorption coefficients of the various elements of the system are majorly relied on it.
  • What are the current market dynamics and opportunities for the key companies operational in medical X-ray detectors market?
  • What is the competitive landscape of medical X-ray detectors market?

Reminder: C-RAD Web Presentation Interim Report Q1 2021 and AGM speech

Retrieved on: 
Tuesday, May 4, 2021
Radiobiology, Radiation, Ionizing radiation, Nuclear physics, Radiation protection, Radioactivity, Medical physics, Absorbed dose, Radiation therapy, Radiation exposure, Rad, Rad

b"After the registration, you will receive a confirmation via email.\nA recording of the presentation will be made accessible on the C-RAD website after the presentation.\nC-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure.

Key Points: 
  • b"After the registration, you will receive a confirmation via email.\nA recording of the presentation will be made accessible on the C-RAD website after the presentation.\nC-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure.
  • Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy.
  • C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.\nC-RAD.
  • Inspiring excellence in cancer treatment.\nC-RAD AB is listed on NASDAQ Stockholm.\n"

Cabaletta Bio Reports Acute Safety Data from the First Dose Cohort in DesCAARTes™ Trial

Retrieved on: 
Monday, May 3, 2021
Academic disciplines, Radiation protection, Radiobiology, Military of ancient Rome, Absorbed dose, Cohort, Dose, Applied mathematics

Infusions are planned to initiate following the third patient in the first dose cohort completing the 28-day monitoring period without any DLTs.

Key Points: 
  • Infusions are planned to initiate following the third patient in the first dose cohort completing the 28-day monitoring period without any DLTs.
  • Cabaletta expects to announce acute safety data for the second and third cohorts in the third and fourth quarters of 2021, respectively.
  • Topline data on target engagement from the first cohort are anticipated during the second half of 2021.
  • The study consists of three parts: 1) dose escalation, 2) dose consolidation, and 3) cohort expansion at the final selected dose and schedule.

C-RAD Web Presentation Interim Report Q1 2021 and AGM speech

Retrieved on: 
Friday, April 23, 2021
Radiobiology, Radiation, Ionizing radiation, Nuclear physics, Radiation protection, Radioactivity, Medical physics, Absorbed dose, Radiation therapy, Radiation exposure, Rad, Rad

b"After the registration, you will receive a confirmation via email.\nA recording of the presentation will be made accessible on the C-RAD website after the presentation.\nC-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure.

Key Points: 
  • b"After the registration, you will receive a confirmation via email.\nA recording of the presentation will be made accessible on the C-RAD website after the presentation.\nC-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure.
  • Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy.
  • C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.\nC-RAD.
  • Inspiring excellence in cancer treatment.\nC-RAD AB is listed on NASDAQ Stockholm.\n"

$ 501.27 Million Growth Expected in the Global Radiation Detection and Monitoring Equipment Market 2021-2025 by Product and Geography- Technavio.com

Retrieved on: 
Thursday, April 8, 2021
Radiation protection, Particle detectors, Radiobiology, Radiation, Ionizing radiation, Medical physics, Nuclear physics

The radiation detection and monitoring equipment market is poised to grow by $ 501.27 million during 2021-2025 progressing at a CAGR of over 5%, owing to the growing demand from healthcare facilities, increasing use of radiation detection and monitoring in different industries, and regulations mandating the use of radiation detection and monitoring equipment.

Key Points: 
  • The radiation detection and monitoring equipment market is poised to grow by $ 501.27 million during 2021-2025 progressing at a CAGR of over 5%, owing to the growing demand from healthcare facilities, increasing use of radiation detection and monitoring in different industries, and regulations mandating the use of radiation detection and monitoring equipment.
  • The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.
  • Our radiation detection and monitoring equipment market research report is covering the current trends and effects on the business of COVID-19.
  • Along with this, the report also provides a detailed analysis of several leading radiation detection and monitoring equipment market vendors and emerging players.

Turning Point Therapeutics Announces Initial Clinical Data From Phase 1/2 SWORD-1 Study of RET Inhibitor TPX-0046

Retrieved on: 
Monday, April 5, 2021
Clinical trials, Nuclear medicine, Radiation protection, Dose-ranging study

The initial data from the Phase 1 dose finding portion of the study showed preliminary clinical activity, including objective responses and a generally well-tolerated safety profile.

Key Points: 
  • The initial data from the Phase 1 dose finding portion of the study showed preliminary clinical activity, including objective responses and a generally well-tolerated safety profile.
  • Turning Point continues to evaluate doses and schedules to determine a recommended Phase 2 dose, and plans to revise the study protocol to include Phase 1 expansion cohorts at the recommended Phase 2 dose.
  • While we continue to evaluate TPX-0046, the initial preliminary data are encouraging, with a generally tolerable safety profile and early signals of activity.
  • Turning Point Therapeutics undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

InventHelp Inventor Develops Improved Way to Secure a Vehicle Glovebox (CBA-3941)

Retrieved on: 
Tuesday, March 30, 2021
Glovebox, Laboratory equipment, Radiation protection, Lock and key, Articles, Science and technology

PITTSBURGH, March 30, 2021 /PRNewswire/ -- "I wanted to create a better way to secure and protect valuable items stored in a vehicle's glovebox," said an inventor, from N. Charleston, S.C., "so I invented the UNIQUE LOCK.

Key Points: 
  • PITTSBURGH, March 30, 2021 /PRNewswire/ -- "I wanted to create a better way to secure and protect valuable items stored in a vehicle's glovebox," said an inventor, from N. Charleston, S.C., "so I invented the UNIQUE LOCK.
  • My design offers an improved alternative to the traditional flimsy key lock on a glovebox door."
  • The invention provides enhanced security for a vehicle's glovebox.
  • The invention features an effective design that is easy to use and secure, so it is ideal for vehicle owners.

GloveBox Receives $3M Early-Stage Investment to Accelerate Growth of Its Mobile and Web Insurance Agent Platform

Retrieved on: 
Friday, March 12, 2021
Glovebox, Laboratory equipment, Radiation protection, Insurance

DENVER, March 12, 2021 /PRNewswire/ --GloveBox, a single sign-on mobile platform that brings together insurance agencies, policyholders, and carriers onto one platform, today announced a $3 million early-stage investment.

Key Points: 
  • DENVER, March 12, 2021 /PRNewswire/ --GloveBox, a single sign-on mobile platform that brings together insurance agencies, policyholders, and carriers onto one platform, today announced a $3 million early-stage investment.
  • The investment will be used to expand features and enhance the functionality of GloveBox's product, benefiting both agencies and policyholders.
  • Co-founders Ryan and Andy Mathisen, Sean Mulhern, and Alex Rolex created GloveBox based on their experiences at Colorado Insurance.
  • "With this funding, we will dramatically expand and accelerate our platform development reaching more agency partners faster and more efficiently.